Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: What prognostic factors are important?

Obstetrics and Gynecology

Volumn 102, Issue 1, 2003, Pages 156-161

  Chan, John K ^a   Loizzi, Vera ^a   Lin, Yvonne G ^a   Osann, Kathryn ^a   Brewster, Wendy R ^a   DiSaia, Philip J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BIOSAFETY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; EPITHELIUM; FEMALE; HEALTH STATUS; HOSPITAL; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 0038384018     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00399-5     Document Type: Article

References (28)

1. Cancer facts and figures 2001. 2001;American Cancer Society Inc, Atlanta.
2. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J Clin. 46:1996;5-27.
3. Nguyen H.N., Averette H.E., Hoskins W., Sevin B.U., Penalver M., Steren A. National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology nd Obstetrics staging system. Cancer. 72:1993;3007-3011.
4. Plaxe S.C., Braly P.S., Freddo J.L., McClay E., Kirmani S., Howell S.B. Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol. 81:1993;651-654.
5. Rodriguez M., Nguyen H.N., Averette H.E., Steren A.J., Penalver M.A., Harrison T., et al. National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age. Cancer. 73:1994;1245-1250.
6. Smedley H., Sikora K. Age as a prognostic factor in epithelial ovarian carcinoma. Br J Obstet Gynaecol. 92:1985;839-842.
7. Swenerton K.D., Hislop T.G., Spinelli J., LeRiche J.C., Yang N., Boyes D.A. Ovarian carcinoma A multivariate analysis of prognostic factors . Obstet Gynecol. 65:1985;264-270.
8. Gloecker-Ries L. Ovarian cancer. Cancer. 71:(Suppl):1993;524-529.
9. Lee C.K., Pires de Miranda M., Ledermann J.A., Ruiz de Elvira M.C., Nelstrop A.E., Lambert H.E., et al. Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy. Eur J Cancer. 35:1999;727-732.
10. Thigpen T., Brady M.F., Omura G.A., Creasman W.T., McGuire W.P., Hoskins W.J., et al. Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience. Cancer. 71:(Suppl):1993;606-614.
11. Massi D., Susini T., Savino L., Boddi V., Amunni G., Colafranceschi M. Epithelial ovarian tumors in the reproductive age group Age is not an independent prognostic factor . Cancer. 77:1996;1131-1136.
12. Duska L.R., Chang Y.C., Flynn C.E., Chen A.H., Goodman A., Fuller A.F., et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer. 85:1999;2623-2629.
13. Holloway S., Brock D.J. Changes in maternal age distribution and their possible impact on demand for prenatal diagnostic services. BMJ. 296:(6627):1988;978-981.
14. Petterson F. Annual report on the results of treatment in gynecological cancer, FIGO, 1994. Vol 22:1994;83-102 International Federation of Gynecology and Obstetrics, Stockholm, Sweden.
15. International histological classification of tumors. 1973;17-18 World Health Organization, Geneva.
16. Gronlund B., Hogdall C., Hansen H.H., Engelholm S.A. Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma. Cancer. 94:2002;1961-1967.
17. Khoo S.K., Battistutta D., Hurst T., Sanderson B., Ward B.G., Free K. The prognostic value of clinical, pathologic, and biologic parameters in ovarian cancer. Cancer. 72:1993;531-537.
18. Redman J.R., Petroni G.R., Saigo P.E., Geller N.L., Hakes T.B. Prognostic factors in advanced ovarian carcinoma. J Clin Oncol. 4:1986;515-523.
19. Griffiths C.T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 42:1975;101-104.
20. Ozols R.F., Garvin A.J., Costa J., Simon R.M., Young R.C. Histologic grade in advanced ovarian cancer. Cancer Treat Rep. 63:1979;255-263.
21. Ozols R.F., Garvin A.J., Costa J., Simon R.M., Young R.C. Advanced ovarian cancer Correlation of histologic grade with response to therapy and survival . Cancer. 45:1980;572-581.
22. Malkasian G.D. Jr, Decker D.G., Webb M.J. Histology of epithelial tumors of the ovary Clinical usefulness and prognostic significance of the histologic classification and grading . Semin Oncol. 2:1975;191-201.
23. Rubin S.C., Benjamin I., Behbakht K., Takahashi H., Morgan M.A., LiVolsi V.A., et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med. 335:1996;1413-1416.
24. Hartmann L.C., Podratz K.C., Keeney G.L., Kamel N.A., Edmonson J.H., Grill J.P., et al. Prognostic significance of p53 immunostaining in epithelial ovarian cancer. J Clin Oncol. 12:1994;64-69.
25. Berchuck A., Carney M. Human ovarian cancer of the surface epithelium. Biochem Pharmacol. 54:1997;541-544.
26. Marks J.R., Davidoff A.M., Kerns B.J., Humphrey P.A., Pence J.C., Dodge R.K., et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res. 51:1991;2979-2984.
27. Schildkraut J.M., Bastos E., Berchuck A. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst. 89:1997;932-938.
28. Kohn E. Aging issues in invasion and metastasis. Cancer. 71:(Suppl):1993;552-557.